GI final material

studied byStudied by 1 person
0.0(0)
get a hint
hint

Acute viral hepatitis time frame

What types of hepatitis are generally chronic

What can chronic hepatitis lead to: (3 things)

1 / 108

Tags and Description

109 Terms

1

Acute viral hepatitis time frame

What types of hepatitis are generally chronic

What can chronic hepatitis lead to: (3 things)

Acute viral hepatitis time frame: < 6 months

What types of hepatitis are generally chronic: B, C, D

What can chronic hepatitis lead to (3 things): Cirrhosis, ESLD, and hepatocellular carcinoma

New cards
2

Clinical presentation of hepatitis:

Most people are generally symptomatic

Flu-like symptoms, fatigue, anorexia, NVD, dark urine, pale stools, abdominal pain

Jaundice, splenomegaly, and extra-hepatic symptoms

New cards
3

Transmission of viral hepatitis: A B C D E

A - fecal/oral B - blood and bodily fluids (perinatal, percutaneous, or sexual) C - Parenteral (contaminated needles/syringes) D - blood and bodily fluids (perinatal, percutaneous, or sexual) E - fecal/oral

New cards
4

Who should be screened for Hep A?

International travelers Contact with an infected person (sex, household, daycare) IVDUs Zookeepers with monkeys Hx clotting factor disorders

New cards
5

Hepatitis B/D - Who should be screened?

International travelers MSM/Multiple heterosexual partners IVDU Healthcare providers/safety workers Residents and staff of facilities for developmentally disabled Hemodialysis Infants born to infected mothers

New cards
6

Hepatitis C - who should be screened?

Everyone > 18 years of age at least once in their lifetime IVDU as yearly HD as yearly Women during each pregnancy

New cards
7

Hepatitis E - who should be screened?

international travelers Ingestion of food/drink contaminated with bodily waste

New cards
8

Vaccinations for hepatitis A

HAVRIX and VAQTA (VAQTA is 2 injections 6 months apart)

New cards
9

vaccines for Hepatitis B/D

Recombivax HB Engerix - B (3 doses at 0, 1, and 6 months) Heplisav - B (adults only)

New cards
10

Vaccine for Hepatitis A/B

Twinrix (usually a 3 dose series)

New cards
11

How is acute hepatitis primarily managed?

Supportive care

New cards
12

Hepatitis A Prevention measures

Good hand washing/proper disposal of waste Vaccination: Lifelong immunity Immunoglobulin IM: passive immunity (Pre-exposure and post-exposure)

New cards
13

Hepatitis A prevention:

  • Pre-exposure: What age ranges can you give IGIM to unvaccinated people to promote passive immunity? What conditions may they have?

-Post-exposure: How long after exposure must it be? Age ranges? Conditions that may be occurring?

Pre-exposure:
New cards
14

Hepatitis B serology: HBsAg

Present on virus cells (indicating virus is currently present) Used to make vaccines

New cards
15

Hepatitis B serology: HBsAb (aka Anti-HBs)

Means your body is mounted a response either to the virus itself OR to the vaccine

New cards
16

Hepatitis B serology: Anti-HBc

You can only have this if you were infected with the virus at some point

New cards
17

Hepatitis B serology: IgM anti-HBc

This is present ONLY during an acute hepatitis infection

New cards
18

Hepatitis B Prevention

Vaccination or HBIG for post-exposure prophylaxis

New cards
19

Treatment for an exposed unvaccinated patient with: HBsAG Positive

Administer HBIG and Hep B vaccine

New cards
20

Treatment for an exposed unvaccinated patient with: HBsAg Unknown

Administer Hep B vaccine

New cards
21

Treatment for an exposed vaccinated patient with: HBsAg Positive

Vaccine booster dose

New cards
22

Treatment for an exposed vaccinated patient with: HBsAg unknown

No Treatment

New cards
23

All oral HBV agents have what BBW?

Lactic acidosis and hepatomegaly

New cards
24

treatment of Chronic HBV: Indicated when: Always test for: Monitoring:

Indicated when: ALT persistently >2x ULN or significant histological disease AND HBV DNA >20,000 IU/mL

Always test for: HIV before treating HBV

Monitoring: LFTs must be monitored if Treatment is discontinued. (severe acute hepatitis exacerbations may occur)

New cards
25

1st line HBV agents: Pegasys (Pegylated IFN-a2a) What does it do: How is it administered: ADRs: CI: How long is treatment?

Effective in suppressing and often ceasing viral replication without resistance

SUBQ administration

ADRs: flu-like symptoms, psych abnormalities, thrombocytopenia/neutropenia

CIs: autoimmune disorders, uncontrolled psych issues, uncontrolled seizures, decompensated cirrhosis

48 week tx course

New cards
26

What does a pegylated IFN mean

A pegylated form increases half-life and allows for less frequent dosing

New cards
27

1st line HBV agents: Baraclude What is it? Approval tx age? Administration? Is it well tolerated?

What is it? Guanosine nucleoside analog Approval tx age? >2 years old Administration? 0.5-1.0mg PO QD on empty stomach Is it well tolerated? Well tolerated

New cards
28

1st line agent: How does Tenofovir work?

Acyclic adenine nucleotide reverse transcriptase inhibitor

New cards
29

First line agent: Tenofovir Disoproxil fumarate (Viread) Dose? Age? RISK:

Dose: 300mg PO QD Age: ≥2 years old RISK: Rare but serious risk of renal toxicity and osteomalacia

New cards
30

First line agent HBV: Tenofovir Alafenamide (Vemlidy) Dose? Age? RISK:

Dose: 25mg PO daily Age: ≥12 years old RISK: Less risk of osteomalacia and renal toxicity than Tenofovir Disoproxil fumarate (Viread)

New cards
31

2nd line HBV treatment: Adefovir dipivoxil (Hepsera) How does it work? Administration Age risks:

How does it work: Adenosine nucleotide analog inhibits DNA Polymerase Administration: 10mg PO QD Age: >12 years risks: Nephrotoxicity, Fanconi syndrome, HIGH RATES OF RESISTANCE

New cards
32

2nd line HBV treatment: Lamivudine (Epivir-HBV) How does it work: Dose Age Benefit Risk

How does it work: Cytosine nucleoside analog Dose: 100mg PO QD (HBV only) for adults Age: approved for >2 years old Benefit: Also effective for HIV Risk: High rates of resistance

New cards
33

Hepatitis C are there vaccines? who is a candidate? Is there a cure?

are there vaccines? No vaccines, no IG products who is a candidate? EVERYONE IS A CANDIDATE FOR Is there a cure? Sustained virological cures exist

New cards
34

Treatment options for Hep C Interferon/ribavirin: Ribavirin is associated with:

Associated with hemolytic anemia, dematological effects, and significant teratogenicity

New cards
35

When using second generation direct-acting antiviral agents EPCLUSA, MAVYRET, and VOSEVI are all _____ and before use you must test for:

EPCLUSA, MAVYRET, and VOSEVI are all pangenotypic

and you must first test for HBV prior to use

New cards
36

Drugs that can interfere with direct acting antivirals

PPIs, Statins, amiodarone, statins, immunosuppressive agents, antimicrobials, St John's wort, antiepileptic agents, Highly active antiretroviral therapy (HAART)

New cards
37

1st line treatment for HCV: Harvoni How does it work: What Genotypes does it work on: What Genotype can is be used on with decompensated cirrhosis? How long is the treatment depending on prior treatment hx, cirrhosis status, genotype, and baseline viral load? Contraindications?

NS5B polymerase inhibitor and a NS5A inhibitor

Genotype 1, 4, 5, and 6

Can be used in type 1 with decompensated cirrhosis

8-24 week treatment depending on prior treatment history, cirrhosis, status, genotype, and baseline viral load

Contraindicated with amiodarone and PPIs

New cards
38

1st line treatment for HCV: Zepatier How does it work? Genotypes When using... test for ____ and you may need to add __

DO NOT USE IN PATIENTS WITH ______

Works by NS5A and NS3/4A protease inhibitor

Genotypes 1 or 4

Test for polymorphisms in 1a disease and you may need to add ribavirin

Do not use in patients with Child-Pugh B or C

New cards
39

1st line treatment for HCV: EPCLUSA How does it work? administration therapy length Can it be used with compensated cirrhosis When should you add ribavirin Contraindications

Works by NS5B polymerase inhibition and NS5A inhibition

PO QD with or without food

12 week therapy

Can be given with or without compensated cirrhosis

Add ribavirin in patients with decompensated Child-pugh B or C cirrhosis

Contraindicated in patients on amiodarone or PPI therapy

New cards
40

1st line treatment for HCV: Vosevi How does it work? Administration and therapy length? Can it be taken with compensated cirrhosis Can it be used in patients with decompensated child-pugh B or C? Contraindications:

Combination drug of Epclusa and voxilaprevir (NS3/4A protease inhibitor) Taken PO QD with food for 12 weeks

Can be taken with or without compensated cirrhosis

Do NOT use in decompensated cirrhosis B or C

CIs: amiodarone and PPI therapy

New cards
41

1st line treatment for HCV: Mavyret How does it work? Administration and therapy length? Can it be used with decompensated child-pugh B and C?

NS3/4A protease inhibitor + NS5 inhibitor

3 tablets PO QD with mod/high fat meal; 8 wk therapy

Do not use in patients with a Child-pugh B or C cirrhosis

New cards
42

NS3/4A PROTEASE inhibitors end in

NS5A inhibitors end in

NS5B inhibitors end in

-Previr

-Asvir

-Buvir

New cards
43

Summary for Harvoni: Is it Pangenotypic? Can it be used in decompensated cirrhosis? Approved in HIV coinfection?

NO

Yes +/- ribavirin

YES

New cards
44

Summary for Zepatier: Is it Pangenotypic? Can it be used in decompensated cirrhosis? Approved in HIV coinfection?

NO

No

NO

New cards
45

Summary for Epclusa: Is it Pangenotypic? Can it be used in decompensated cirrhosis? Approved in HIV coinfection?

Yes

Yes +/- Ribavirin

Yes

New cards
46

Summary for Vosevi: (combination of Epclusa and voxilaprevir) Is it Pangenotypic? Can it be used in decompensated cirrhosis? Approved in HIV coinfection?

Yes

NO

No

New cards
47

Summary for Mavyret: Is it Pangenotypic? Can it be used in decompensated cirrhosis? Approved in HIV coinfection?

Yes

No it cannot

Yes

New cards
48

What does only have a IgM (+) mean?

Acute infection

New cards
49

What does (+) HBSAB and (-) Anti-HBc mean?

Immune by vaccination

New cards
50

What does (+) HBSAB and (+) HBCAB mean?

Immune by natural infection or virus

New cards
51

What does (+) HBSAg and (+) Anti-HBC indicate?

Chronic infection

New cards
52

What does it mean if all serology tests come back negative for a patient?

They are susceptible for HBV

New cards
53

IgM anti-HBC (+) occurs only during

Acute infection

New cards
54

What two times does HBSAg occur in the body?

Vaccination and when virus is alive and active

New cards
55

What does it mean that you have HBSAb?

Resolved infection or mounted immune response from vaccine

New cards
56

What does having anti-HBC in you mean?

HepB virus was or IS in you

New cards
57

6 things that can lead to cirrhosis?

What is the outcome of having cirrhosis?

What is a consequence (3) of liver fibrosis?

Alcohol, HCV, Metabolic liver disease, immunologic disease, vascular damage, or drugs

Having cirrhosis can lead to an advanced stage of liver fibrosis

Advanced stage liver fibrosis can lead to impaired hepatocyte function, Portal HTN, and hepatocellular carcinoma

New cards
58

(Pathophysiology of Cirrhosis) activation of _____ cells

_____ cells lose vitamin A, proliferate, and synthesize __________

Fibrosis results in loss of hepatocyte _____ and deterioration of hepatocyte _____

If fibrosis progresses, _____ occurs

activation of stellate cells

stellate cells lose vitamin A, proliferate, and synthesize fibrotic scar tissue

Fibrosis results in loss of hepatocyte microvilli and deterioration of hepatocyte function

If fibrosis progresses, cirrhosis occurs

New cards
59

Hepatic fibrosis leads to (4 things)

Splanchnic vasodilation Decreased responsiveness of vasoconstrictors Formation of new blood vessels Portal-systemic shunting

New cards
60

Portal Hypertension is classified by (4 things):

Hypervolemia Increased cardiac index (relation of output to BSA) Hypotension Decreased systemic vascular resistance

New cards
61

5 classifications of the Child-Pugh score

Does it:

Excrete bilirubin Metabolize drugs make clotting factors make thrombopoeitin make albumin

New cards
62

Symptoms of cirrhosis

Asymptomatic enlarged liver or spleen Laundice, spider angiomata, hyperpigmentation Gynecomastia, reduced libido Ascites, edema, pleural effusion Malaise, anorexia, weight loss, encephalopathy

New cards
63

Lab values to watch with cirrhosis

prothrombin time thrombocytopenia elevated alkaline phosphatase elevated AST, ALT, or GGT

New cards
64

Define the 3 types of hepatic encephalopathy: Episodic HE Recurrent HE Persistent HE

Episodic HE: refers to precipitated, spontaneous, or recurrent acute episodes of HE

Recurrent HE: refers to episodes of HE that occur within a time interval of 6 months or less

Persistent HE: a pattern of behavioral alterations that are always present (treatment dependent) and are interspersed with relapses of overt HE

New cards
65

Clinical presentation of HE: what 3 things are we looking for?

Level of consciousness changes Personality/intellect changes Neurological abnormalities (tremor, incoordination, abnormal reflexes, etc.)

New cards
66

Generalized treatment goals for hepatic encephalopathy (3 generalized things)

Decrease ammonia blood concentrations by reducing the nitrogenous load from the gut

identify and correct precipitating factors

nutritional management (protein restrictions)

New cards
67

Hepatic encephalopathy: first line drugs and second line drugs

First line drugs: Lactulose and rifaximin

Second line: Metronidazole and neomycin

New cards
68

Mainstay of HE treatment: Lactulose How does it work? Dosing? How should it be titrated? How can it ALSO be given?

Lactulose reduces ammonia production by the small intestine and leaches ammonia from circulation into the colon for excretion

start at 45 mL PO Q1H until catharsis, decrease dose as time goes on to 15-45mL every 8-12 hours

Titrated to produce 2-3 stools per day

New cards
69

How does Rifaximin work? Pro and con of it

It inhibits bacterial RNA synthesis by binding to bacterial DNA-dependent RNA polymerase

It has a favorable side effect profile but it is more expensive than lactulose

New cards
70

Second line options for HE: Metronidazole/Neomycin

How do they work?

Neomycin: ADE and monitoring

Metronidazole: ADE

Inhibit the activity of urease-producing bacteria and decreases production of ammonia

Neomycin: ototoxicity and nephrotoxicity (annual auditory and periodic renal monitoring)

Metronidazole: Neurotoxicity

New cards
71

Cirrhosis/portal HTN can lead to ascites due to an increase in nitric oxide causing systemic/splanchnic vasodilation.

Decreased effective arterial blood volume occurs and the RAAS system gets activated.

What does this cause in relation to ascites?

Hyperdynamic circulation, sodium and water retention, renal vasoconstriction

New cards
72

We should consider paracentesis if the patient has:

New onset ascites Tense ascites Refractory ascites

New cards
73

When should albumin replacement be considered in patients undergoing paracentesis

When more than >5L are removed from the body.

New cards
74

Treatment of ascites: -fluid -diet -drug -procedure

-fluid: culture the fluid pulled from paracentesis to assess bacterial risk -diet: restrict sodium to less than 2000mg/day -drug: Spironolactone:Furosemide. 100:40 ratio -procedure: Transjugular intrahepatic portosystemic shunt can be considered in refractory patients

New cards
75

Spontaneous Bacterial Peritonitis can result from increased intestinal wall permeability, translocation of bacteria into mesenteric lymph nodes, and seeding into ascitic fluid

What are the primary bacteria that occur in SBP

What should we use to treat SBP

Escherichia Coli, Klebsiella Pneumonia, and Streptococcus Pneumoniae

Empiric treatment with third-generation cephalosporins like Ceftriaxone and Cefotaxime

New cards
76
Long term SBP prophylaxis should be done if the patient has a history of SBP or low-protein ascites with lab of SCr >1.2, BUN >25, Na

Sulfamethoxazole/trimethoprim (Bactrim) Ciprofloxacin

New cards
77

Primary prevention of esophageal varices drug options: What they do:

Non-selective beta-blockers: Propranolol and Nadolol Decrease CO and decrease splanchnic blood flow

New cards
78

Another primary prophylactic measure: Endoscopic variceal ligation can be considered for _____

patients with contraindications to beta-blockers or high-risk medium to large varices

New cards
79

What medication choice should you use small varices or risk factors

Beta Blockers

New cards
80

Acute Variceal Hemorrhage: 3 main things Stabilize the patient Control hemorrhage Prevent complications (SBP)

Stabilize the patient: normalize HR, BP, Hgb >7, avoid aggressive resus with NS

Control hemorrhage: pharmacologic plus endoscopic therapy, correct coagulopathy

Prevent complications (SBP): Ceftriaxone and Ciprofloxain

New cards
81

Octreotide: how does it work where does it work what does it cause DOSING

how does it work: Inhibits release of vasodilatory peptides (more potent, longer DOA)

where does it work: binds selectively to splanchnic vasculature

what does it cause: Reduction in portal pressure and port-collateral blood flow

DOSING: 50 mcg IV bolus followed by 50 mcg/hr

New cards
82

Octreotide side effects:

bradycardia, hyperglycemia, vomiting, hypertension

New cards
83

Secondary Prophylaxis Combination therapies: Heart rate range for beta blockers: TIPS should be considered for ____

Combination therapies: combination of non-selective beta-blockers plus EVL is preferred (Primarily Nadolol and propranolol)

Heart rate range for beta blockers: 55-60 BPM

TIPS should be considered for: Child-Pugh A/B who are refractory to Beta Blockers plus EVL

New cards
84

Hepatorenal syndrome: What is it drugs to stop drugs to use Only definitive treatment

Intense renal vasoconstriction caused by systemic vasodilation Discontinue diuretics Use: Octeotide and midodrine Liver transplant is the only definitive treatment

New cards
85

Terlivaz (terlipressin): how should it be adjusted Most common side effect and BBW: Contraindications

how should it be adjusted: By SCr response Most common side effect and BBW: Respiratory failure Contraindications: Do not use in patients with SCr >5 or hypoxic

New cards
86

Systemic complications: Hepatopulmonary syndrome

defect in arterial oxygenation caused by systemic vasodilation supportive therapy with oxygen Liver transplant is only definitive cure

New cards
87

Systemic complications: Coagulopathy

Impaired synthesis of clotting factors, excessive fibrinolysis, etc. Usually only corrected during active bleeding

New cards
88

Systemic complications: Endocrine disorders

hypogonadism DM Osteoporosis Thyroid disorders

New cards
89

Consequences of PK/PD changes in liver cirrhosis (4 things)

Reduction in intrinsic metabolic activity reduction in delivery of blood to the liver Decreased protein binding increased interstitial fluid

New cards
90

PK/PD Changes in the body are _____ through out the whole disease course

Dynamic

New cards
91

NASH (Non-alcohol Steatohepatitis) What is it? Risk factors? Treatments?

Build up of of extra fat in liver cells leading to a fatty liver and swelling causing cirrhosis

Risk factors: overweight/obese, DM, high colesterol/HyperTG

There are no current treatments - just control underlying causes

New cards
92

Lobule in the liver is made up of what? Whats in the corners? what do we call cells close to the center of the lobule? How does blood flow from the heart/body to and through the liver? What do Reticuloendothelial cells (Kupffer cells) do in the lobule?

Many cells surrounding a central vein in the middle of the hexagon.

In the corners are portal triads with: a bile duct, a branch of the hepatic portal vein, and a branch of the hepatic artery

Central lobular hepatocytes exist close to the center of a lobule

Blood flows from the outside (triads) inward toward the central veins of the lobules. This mixes nutrient-rich blood from the GI and Oxygen-rich blood from the heart

They break down old RBCs and act as minor immune cells

New cards
93

How does blood move through the liver and how does bile move through the liver?

Blood flows from the hepatic artery (oxygen rich) and the hepatic portal vein (GI rich) to the liver sinusoids, to the central vein, to the hepatic veins, inferior vena cava, right atrium

Bile from the left and right hepatic duct mix in the common hepatic duct of the liver, and cystic duct from the gallbladder mixes in, then to the common bile duct. The pancreatic duct mixes in. Then into the duodenum

New cards
94

Most common agents that cause hepatotoxicity?

APAP, anti-infectives, antiepileptics, and isoniazid

New cards
95

Define the following:

Intrinsic hepatotoxicity: Idiosyncratic hepatotoxicity: Chronic DILI:

Intrinsic hepatotoxicity: toxicity with potential to affect all individuals to varying degrees. Reactions typically stereotypic and dose dependent (acetaminophen)

Idiosyncratic hepatotoxicity: toxicity that affects only rare susceptible individuals. Reaction is less dose-dependent and more varid in larency, presentation, and course

Chronic DILI: failure of liver enzymes or bilirubin to return to pre-DILI baseline and/or other signs/symptoms of ongoing liver disease 6 months after DILI onset.

New cards
96

pathophysiology of Centrilobular necrosis: Pathophysiology of steatohepatitis/steatonecrosis: ---- what interesting drugs can cause this? Pathophysiology of phospholipidosis: Pathophysiology of generalized hepatocellular necrosis: Pathophysiology of toxic cirrhosis

direct tissue damage permanent or reversible that results from introduction of agent

Accumulation of fatty acids in hepatocytes via reduction in oxidation rate within mitochondria of hepatocyte interrupting homeostasis ----- ethanol and tetracyclines (IV doses >1/5g QD)

Accumulation of phospholipids in the hepatocyte engorge lysosomal bodies, leading to disruption in mitochondrial or lysosomal activity

Non-toxic metabolites undergo bioactivation in the liver binding to proteins and creating haptens that trigger an immune response leading to an immune response damaging the liver

Hepatitis causes scar tissue to develop ultimately leading to a reduction in liver function

New cards
97

Pathophysiology of cholestatic injury ---- what can cause this? Pathophysiology of Mixed hepatocellular injury Pathophysiology of Liver vascular disorders

disturbance of subcellular actin filaments preventing movement of bile through the canalicular system ----TPN >1 week, augmentin

Combination of any hepatocellular/cholestatic process

Focal lesions in hepatic venules, sinusoids, and portal veins occur with drug administration. Occlusion, hemorrhaging, or compromised patency are common manifestations

New cards
98

Diagnosis of DILD --Gold standard? --when should it be considered and how can it be found?

gold standard: consensus of expert opinion

it should always be considered and things might have to be rechallenged in order to find it.

New cards
99

Clinical presentation of DILD? (4 things)

Asymptomatic transaminitis Malaise, abd pain, nausea, anorexia Jaundice Acute Liver failure symptomatology

New cards
100

Clinical presentation of acute liver failure: (5 things)

Jaundice INR >1.5 while not on anticoagulation Hypo/hyperglycemia Pruritus Hepatic encephalopathy

New cards

Explore top notes

note Note
studied byStudied by 84 people
Updated ... ago
4.8 Stars(4)
note Note
studied byStudied by 40 people
Updated ... ago
4.5 Stars(4)
note Note
studied byStudied by 7 people
Updated ... ago
5.0 Stars(1)
note Note
studied byStudied by 20 people
Updated ... ago
5.0 Stars(1)
note Note
studied byStudied by 106 people
Updated ... ago
5.0 Stars(1)
note Note
studied byStudied by 17 people
Updated ... ago
5.0 Stars(1)
note Note
studied byStudied by 25 people
Updated ... ago
5.0 Stars(1)
note Note
studied byStudied by 6 people
Updated ... ago
5.0 Stars(1)

Explore top flashcards

flashcards Flashcard24 terms
studied byStudied by 2 people
Updated ... ago
5.0 Stars(1)
flashcards Flashcard32 terms
studied byStudied by 19 people
Updated ... ago
5.0 Stars(2)
flashcards Flashcard40 terms
studied byStudied by 6 people
Updated ... ago
5.0 Stars(1)
flashcards Flashcard55 terms
studied byStudied by 3 people
Updated ... ago
5.0 Stars(1)
flashcards Flashcard20 terms
studied byStudied by 12 people
Updated ... ago
5.0 Stars(3)
flashcards Flashcard31 terms
studied byStudied by 13 people
Updated ... ago
5.0 Stars(1)
flashcards Flashcard46 terms
studied byStudied by 5 people
Updated ... ago
5.0 Stars(1)
flashcards Flashcard21 terms
studied byStudied by 5 people
Updated ... ago
5.0 Stars(2)